CONTACT US   SITE MAP   SEARCH


 
 
Investor Relations Home
Investor Events
Featured Reports
DateTitle
05/01/09
Download Documentation 2009 SuperGen Proxy
04/27/09
Download Documentation 2008 Annual Report
04/14/09
Download Documentation Analyst Day
Get help downloading or viewing the above file types
Corporate Profile
SuperGen is a pharmaceutical company whose mission is to prolong, improve the quality of and ultimately, save the lives of those people afflicted with life-threatening diseases, especially cancer.

The company possesses a broad portfolio of proprietary cancer therapies that target a variety of solid tumors, hematological malignancies and blood disorders, offering renewed hope to patients who suffer from these illness... More >>

Stock Quote
SUPG (common stock)
ExchangeNASDAQ GM (US Dollar)
Price$2.05
Change (%)0.00 (0.00%)
Volume454,381
Data as of 07/02/09 4:00 p.m. ET
Minimum 20 minute delay
Refresh quote
Recent NewsMore >>
Date Title
05/04/09Printer Friendly VersionSuperGen's MP-470 Demonstrates Clinical Benefit in Lung Cancer Patients
05/01/09Printer Friendly VersionSuperGen Announces Departure of Chief Medical Officer
04/27/09Printer Friendly VersionSuperGen Reports 2009 First Quarter Financial Results
04/21/09Printer Friendly VersionSuperGen Identifies New Class of Etk/Bmx Kinase Inhibitors
Copyright © 2008 MarketWatch, Inc. All rights reserved. Please see our Terms of Use.
Designed and powered by Dow Jones Client Solutions
Intraday data provided by Interactive Data Real Time Services and subject to the Terms of Use.
Intraday data is at least 20-minutes delayed. All times are ET.
Historical and current end-of-day data provided by Interactive Data Pricing and Reference Data.
Privacy Policy
Terms/Conditions
Copyright © Supergen